Advisornet Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-101
| Closed | -$9.6K | – | 2184 |
|
2024
Q3 | $9.6K | Sell |
101
-100
| -50% | -$9.5K | ﹤0.01% | 1420 |
|
2024
Q2 | $18.4K | Buy |
201
+1
| +0.5% | +$91 | ﹤0.01% | 1106 |
|
2024
Q1 | $18.2K | Hold |
200
| – | – | ﹤0.01% | 1103 |
|
2023
Q4 | $16.3K | Hold |
200
| – | – | ﹤0.01% | 1158 |
|
2023
Q3 | $16K | Hold |
200
| – | – | ﹤0.01% | 1104 |
|
2023
Q2 | $15.8K | Hold |
200
| – | – | ﹤0.01% | 1186 |
|
2023
Q1 | $15.5K | Hold |
200
| – | – | ﹤0.01% | 1164 |
|
2022
Q4 | $15.5K | Sell |
200
-34
| -15% | -$2.64K | ﹤0.01% | 1137 |
|
2022
Q3 | $16K | Sell |
234
-52
| -18% | -$3.56K | ﹤0.01% | 1182 |
|
2022
Q2 | $22K | Hold |
286
| – | – | ﹤0.01% | 1090 |
|
2022
Q1 | $23K | Sell |
286
-4
| -1% | -$322 | ﹤0.01% | 1197 |
|
2021
Q4 | $22K | Hold |
290
| – | – | ﹤0.01% | 1257 |
|
2021
Q3 | $21K | Buy |
290
+46
| +19% | +$3.33K | ﹤0.01% | 1234 |
|
2021
Q2 | $18K | Buy |
244
+32
| +15% | +$2.36K | ﹤0.01% | 1253 |
|
2021
Q1 | $15K | Sell |
212
-4
| -2% | -$283 | ﹤0.01% | 1256 |
|
2020
Q4 | $14K | Hold |
216
| – | – | ﹤0.01% | 1203 |
|
2020
Q3 | $13K | Sell |
216
-584
| -73% | -$35.1K | ﹤0.01% | 1194 |
|
2020
Q2 | $50K | Buy |
+800
| New | +$50K | ﹤0.01% | 851 |
|